Delivery Order SPE2DB22D3019-SPE2DB25FK3NH
Award Date
4/25/25
Potential Completion Date
4/28/25
Potential Value
$8.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,910.94, is for the delivery of dexamethasone 0.5 mg/5 ml elixir, a medical product used for various medical treatments. The contract has a completion date of March 27, 2025 and is a firm fixed-price delivery order. No set-aside designation was used for this award. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dexamethasone 20 mg/5 ml vials, a medication used to treat various conditions. The contract has a ceiling value of $6,165.50 and is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,182.24, is for the delivery of 4,566,189,769 milliliters of dexamethasone 10 mg/mL vials. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 25, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXAMETHASONE 0.5 MG/5 ML ELX 237ML, a pharmaceutical product, with a ceiling value of $1,939.02 and a period of performance through May 21, 2025. The contract is a firm fixed price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXAMETHASONE 20 MG/5 ML VIAL 5ML medication. The contract has a firm fixed price, with a ceiling value of $3,916.14, and a period of performance through May 27, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Dexamethasone 20 mg/5 ml vials. The firm-fixed-price contract has a ceiling value of $1,491.26 and an ultimate completion date of August 30, 2024. This contract is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of the company's extensive federal contracting activities...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,236.93, is for the delivery of 4568346564 Dexamethasone 20 mg/5 mL vials. The contract has an ultimate completion date of May 27, 2025. Amerisourcebergen Drug Corp is the prime contractor and this award is not associated with a set-aside program. The company holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,715.78, is for the delivery of dexamethasone 20 mg/5 ml vials with a final completion date of April 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,943.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564572082 - DEXAMETHASONE 0.5 MG/5 ML ELX 237ML, a pharmaceutical product. The contract has an ultimate completion date of May 13, 2024 and is a firm fixed-price delivery order. There is no set-aside designation mentioned in the award information provided....
This is a $2,547.92 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for the delivery of DEXAMETHASONE 0.5 MG/5 ML ELX 237ML, a medication, with a performance period ending on May 29, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global...